## Abstract Although monoclonal antibodies are increasingly used for cancer therapy, remissions are only temporary due to emergence of tumor cell escape variants that are no longer affected by the antibody. The emergence of escape variants could be minimized by multiβtargeting of tumor cells with p
β¦ LIBER β¦
Manufacture of recombinant polyclonal antibodies
β Scribed by S. K. Rasmussen; L. K. Rasmussen; D. Weilguny; A. B. Tolstrup
- Book ID
- 106363842
- Publisher
- Springer Netherlands
- Year
- 2007
- Tongue
- English
- Weight
- 468 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0141-5492
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Recombinant polyclonal antibodies for ca
β
Jacqueline Sharon; Meredith A. Liebman; Brent R. Williams
π
Article
π
2005
π
John Wiley and Sons
π
English
β 178 KB
Recombinant polyclonal antibodies: the n
β
John S. Haurum
π
Article
π
2006
π
Elsevier Science
π
English
β 265 KB
Single-Batch Production of Recombinant H
β
Lars S. Nielsen; Alexandra Baer; Christian MΓΌller; Kristian Gregersen; Nina T. M
π
Article
π
2010
π
Humana Press Inc
π
English
β 494 KB
Generation of Polyclonal Antibodies Agai
β
Juliana Branco Novo; Maria Leonor Sarno Oliveira; Geraldo Santana MagalhΓ£es; Lig
π
Article
π
2010
π
Humana Press Inc
π
English
β 326 KB
Production of target-specific recombinan
β
Finn C. Wiberg; SΓΈren K. Rasmussen; Torben P. Frandsen; Lone K. Rasmussen; Kaja
π
Article
π
2006
π
John Wiley and Sons
π
English
β 494 KB
π 1 views
## Abstract We describe the expression and consistent production of a first targetβspecific recombinant human polyclonal antibody. An antiβRhesus D recombinant polyclonal antibody, Sym001, comprised of 25 unique human IgG1 antibodies, was produced by the novel Sympress expression technology. This s
Production of Polyclonal Antibodies to P
β
Noemi Cerovska; Tomas Moravec; Helena Plchova; Hana Hoffmeisterova; Jitka Folwar
π
Article
π
2010
π
John Wiley and Sons
π
English
β 82 KB